ProfileGDS5678 / 1460201_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 113.171199
GSM967853U87-EV human glioblastoma xenograft - Control 213.177699
GSM967854U87-EV human glioblastoma xenograft - Control 313.158699
GSM967855U87-EV human glioblastoma xenograft - Control 412.949399
GSM967856U87-EV human glioblastoma xenograft - Control 513.295499
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 113.266999
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 213.174199
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 313.20699
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 413.197499
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 113.196699
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 213.193999
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 313.217899
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 413.172399
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 513.255699